BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28238903)

  • 1. Responsiveness to bronchodilator procaterol in COPD as assessed by forced oscillation technique.
    Ito S; Uchida A; Isobe Y; Hasegawa Y
    Respir Physiol Neurobiol; 2017 Jun; 240():41-47. PubMed ID: 28238903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of airway responsiveness using colored three-dimensional analyses of a new forced oscillation technique in controlled asthmatic and nonasthmatic children.
    Murakami K; Habukawa C; Kurosawa H; Takemura T
    Respir Investig; 2014 Jan; 52(1):57-64. PubMed ID: 24388372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Inhaled Procaterol for Potential Assist Use in Patients with Stable Chronic Obstructive Pulmonary Disease.
    Kodaka N; Yamagishi T; Watanabe K; Kishimoto K; Nakano C; Oshio T; Niitsuma K; Shimada N; Matsuse H
    Med Princ Pract; 2018; 27(4):350-355. PubMed ID: 29772569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchodilator Responses in Respiratory Impedance, Hyperinflation and Gas Trapping in COPD.
    Milne S; Hammans C; Watson S; Farah CS; Thamrin C; King GG
    COPD; 2018; 15(4):341-349. PubMed ID: 29799289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
    Kamada T; Kaneko M; Tomioka H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualized changes in respiratory resistance and reactance along a time axis in smokers: a cross-sectional study.
    Shinke H; Yamamoto M; Hazeki N; Kotani Y; Kobayashi K; Nishimura Y
    Respir Investig; 2013 Sep; 51(3):166-74. PubMed ID: 23978643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of procaterol on exercise dynamic lung hyperinflation during the 6-min walk test in stable patients with chronic obstructive pulmonary disease.
    Satake M; Takahashi H; Sugawara K; Kawagoshi A; Tamaki A; Homma M; Morita R; Sato K; Sano M; Shioya T
    Arzneimittelforschung; 2011; 61(1):8-13. PubMed ID: 21355441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory system reactance reflects communicating lung volume in chronic obstructive pulmonary disease.
    Milne S; Jetmalani K; Chapman DG; Duncan JM; Farah CS; Thamrin C; King GG
    J Appl Physiol (1985); 2019 May; 126(5):1223-1231. PubMed ID: 30763164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.
    Diba C; King GG; Berend N; Salome CM
    Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effect of the beta2-receptor agonist procaterol on daily life performance and exercise capacity in patients with stable chronic obstructive pulmonary disease. Clinical study with special reference to health-related quality of life and activities of daily living.
    Shioya T; Satake M; Sato K; Sano MA; Sugawara K; Takahashi H; Honma M
    Arzneimittelforschung; 2008; 58(1):24-8. PubMed ID: 18368947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of inspiratory and expiratory resistance and reactance in patients with asthma and chronic obstructive pulmonary disease.
    Paredi P; Goldman M; Alamen A; Ausin P; Usmani OS; Pride NB; Barnes PJ
    Thorax; 2010 Mar; 65(3):263-7. PubMed ID: 20335298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.
    Pisi R; Aiello M; Zanini A; Tzani P; Paleari D; Marangio E; Spanevello A; Nicolini G; Chetta A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1191-7. PubMed ID: 26150710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation.
    Kitaguchi Y; Yasuo M; Hanaoka M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():991-7. PubMed ID: 27274220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD.
    DellacĂ  RL; Pompilio PP; Walker PP; Duffy N; Pedotti A; Calverley PM
    Eur Respir J; 2009 Jun; 33(6):1329-37. PubMed ID: 19164347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute effect of inhaled beta(2)-agonists with different type of intrinsic activity on airway resistance in healthy volunteers].
    Kishimoto N; Ohnishi H; Fujita J; Kamei T; Tada S; Ueda N
    Arerugi; 2004 Apr; 53(4):417-22. PubMed ID: 15187486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Day-to-day variability of oscillatory impedance and spirometry in asthma and COPD.
    Timmins SC; Coatsworth N; Palnitkar G; Thamrin C; Farrow CE; Schoeffel RE; Berend N; Diba C; Salome CM; King GG
    Respir Physiol Neurobiol; 2013 Jan; 185(2):416-24. PubMed ID: 22960661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of inhaled tiotropium plus transdermal tulobuterol versus tiotropium alone on impulse oscillation system (IOS)-assessed measures of peripheral airway resistance and reactance, lung function and quality of life in patients with COPD: a randomized crossover study.
    Abe T; Setoguchi Y; Kono Y; Togashi Y; Sugiyama S; Tanakadate M; Soeda S; Nakai M; Sugiyama N; Fujiwara A; Yamaguchi K; Yamaguchi A; Kurita N
    Pulm Pharmacol Ther; 2011 Oct; 24(5):617-24. PubMed ID: 21689775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colored 3-dimensional analyses of respiratory resistance and reactance in COPD and asthma.
    Mori K; Shirai T; Mikamo M; Shishido Y; Akita T; Morita S; Asada K; Fujii M; Suda T; Chida K
    COPD; 2011 Dec; 8(6):456-63. PubMed ID: 22149407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchodilator response of advanced lung function parameters depending on COPD severity.
    Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expiratory flow limitation relates to symptoms during COPD exacerbations requiring hospital admission.
    Jetmalani K; Timmins S; Brown NJ; Diba C; Berend N; Salome CM; Wen FQ; Chen P; King GG; Farah CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():939-45. PubMed ID: 25999709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.